Back To Schedule
Thursday, June 18 • 5:00pm - 6:00pm
#526 OD: ON DEMAND - Assessing the Adoption of Clinical Trial Results Summary Disclosure to Patients and the Public

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate

This session discusses why adoption of plain language summaries remains low and suggests that the absence of clear regulatory requirements and their enforcement are the primary cause.

Learning Objectives

Assess the adoption rate of clinical trial results summary disclosure to patients and the public; Review the current lay summary regulatory environment; Analyze current adoption barriers to delivering clinical trial results summaries.


Jill McNair, MBA


Assessing the Adoption Rate of Clinical Trial Results Summary Disclosure
Jill McNair, MBA

Review the Current Lay Summary Environment and Discuss the Implementation Journey
Julie G. Holtzople

avatar for Julie Holtzople

Julie Holtzople

Senior Director Clinical Transparency and Data Sharing, AstraZeneca, United States
Julie Holtzople is the Sr. Director of Clinical Transparency & Data Sharing for AstraZeneca and co-lead of the CREG CTT group. Julie received her Bachelors of Science in Business Administration at Virginia Polytechnic Institute. Julie has been with AstraZeneca for 14 years. Prior... Read More →
avatar for Jill McNair

Jill McNair

Senior Director, Health Communication Services, CISCRP
Jill has worked in the non-profit sector for over 20 years. She is the Senior Director, Health Communication Services at CISCRP. In this role, she oversees a team dedicated to helping sponsor companies provide trial results summaries in plain language to study volunteers. She is passionate... Read More →

Thursday June 18, 2020 5:00pm - 6:00pm EDT
TBD Virtual Event Horsham, PA 19044
  04: MedAffairs-SciComm, Session